MDxHealth SA (MDXH.BR)
BE0974461940 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 15.50M | 58.50M | 16.00M | 22.10M | |||
| Cash Equivalents | 32.70M | 15.50M | N/A | N/A | 22.05M | |||
| Receivables | 8.60M | 9.50M | 5.10M | 3.90M | 6.70M | |||
| Inventories | 2.90M | 2.30M | 1.90M | 2.30M | 1.20M | |||
| Other Current Assets | 1.50M | 1.80M | 1.10M | 1.00M | 1.00M | |||
| Total Current Assets | 45.60M | 29.10M | 66.60M | 23.10M | 30.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.80M | 7.90M | 5.00M | 3.70M | 2.50M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 35.90M | 35.90M | N/A | N/A | 0.00 | |||
| Intangibles | 44.40M | 46.20M | 3.40M | 5.10M | 7.30M | |||
| Total Non-Current Assets | 90.10M | 90.00M | 8.50M | 8.80M | 9.70M | |||
| TOTAL ASSETS | 135.70M | 119.10M | 75.10M | 31.90M | 40.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.00M | 1.80M | 5.30M | 3.60M | 1.20M | |||
| Accrued Expenses | N/A | 9.10M | 7.00M | 5.60M | 5.70M | |||
| Accounts Payable | 8.90M | 5.10M | 3.20M | 2.90M | 2.60M | |||
| Other Current Liabilities | 7.90M | 2.30M | 1.00M | 900.00K | 900.00K | |||
| Total Current Liabilities | 18.80M | 18.30M | 16.40M | 13.00M | 10.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 38.70M | 38.00M | 10.30M | 12.30M | 9.80M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 60.30M | 53.50M | 1.50M | 700.00K | 700.00K | |||
| Total Non-Current Liabilities | 99.10M | 91.50M | 11.80M | 13.00M | 10.50M | |||
| TOTAL LIABILITIES | 117.90M | 109.80M | 28.20M | 26.00M | 20.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -307.90M | -276.90M | -233.70M | -205.90M | -178.50M | |||
| Additional Paid In Capital | 153.20M | 153.20M | 153.20M | 136.30M | 136.30M | |||
| Common Shares | 173.10M | 133.50M | 128.50M | 76.70M | 62.80M | |||
| Other Shareholders' Equity | -500.00K | -400.00K | -1.00M | -1.30M | -900.00K | |||
| Shares Outstanding | 27.00M | 16.30M | 15.60M | 9.10M | 7.10M | |||
| Tangible Book Value per Share | -2.31 | -4.47 | 2.79 | 0.08 | 1.75 | |||
| Total Shareholders' Equity | 17.80M | 9.30M | 46.90M | 5.80M | 19.70M | |||
| TOTAL LIABILITIES AND EQUITY | 135.70M | 119.10M | 75.10M | 31.90M | 40.60M | |||
| Statistics | ||||||||
| Debt/Equity | 2.17 | 4.09 | 0.22 | 2.12 | 0.50 | |||
| Current Ratio | 2.43 | 1.59 | 4.06 | 1.78 | 2.97 | |||
| Return On Assets (ROA) | -51.61% | -36.98% | -38.62% | -89.84% | -106.16% | |||
| Return On Equity (ROE) | -393.48% | -473.55% | -61.83% | -494.14% | -218.78% | |||
All data in USD